$1.16
-0.19-13.81%
At close: Nov 11, 4:00 PM EST
$1.12
-0.22-16.42%
Pre-Market: 5:14 AM EST
Tvardi Therapeutics Inc (TVRD) Stock Price, Quote, News & History
TVRDNASDAQ
Tvardi Therapeutics stock dips premarket as investors take profits after positive Phase 1 data for Tvardi's STAT3 prodrug TTI-109.
You can purchase shares of Tvardi Therapeutics (NASDAQ:TVRD) through any online brokerage.
Other companies in Tvardi Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Tvardi Therapeutics has a consensus price target of $11.38.
The stock price for Tvardi Therapeutics (NASDAQ: TVRD) is $1.12 last updated November 13, 2026 at 7:14 AM EST.
There are no upcoming dividends for Tvardi Therapeutics.
Tvardi Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tvardi Therapeutics.
Tvardi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative...
